How much funding has Tagomics raised?

Tagomics has raised $8.5M in total funding, most recently a Series A round.

Where is Tagomics headquartered?

Tagomics is headquartered in Cambridge, United Kingdom.

What industry is Tagomics in?

Tagomics operates in Biotech, Healthcare.

Tagomics

Q: Who are Tagomics's investors?

Tagomics's investors include Calculus Capital, Illumina Ventures, IQ Capital Partners.

Cambridge, United Kingdom · Founded 2021 · $8.5M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 1–10
Founded: 2021
Business Model: B2B

Website: tagomics.com
Total Funding: $8.5M
Last Round: $8.5M Series AFeb 2024
Rounds: 1

About

Tagomics is a Cambridge-based biotechnology company founded in 2021 as a University of Birmingham spinout, working to transform disease diagnosis through comprehensive multiomic profiling. The company combines genomics and a proprietary epigenetics technology to create cell-free DNA (cfDNA)-based multi-omic biomarkers for early cancer detection and precision medicine. Co-founded by Dr. Jack Kennefick (CEO) and Dr. Robert Neely (CSO), Tagomics partners with companies such as Agilent Technologies to advance its platform.

Summary

Tagomics is a Biotech company based in Cambridge, United Kingdom, founded in 2021. It has raised $8.5M in total across 1 round, most recently a $8.5M Series A round in Feb 2024. Investors include Calculus Capital, Illumina Ventures and IQ Capital Partners.